
Quinine Sulfate is a premium-grade, white crystalline powder natural cinchona alkaloid antibiotic compound carrying CAS number 6119-70-7. Processed under strict pharmaceutical compliance, this high-purity antimalarial active substance exhibits exceptional schizontocidal inhibition efficiency and reliable molecular matrix stability, making it an ideal core choice for manufacturing clinical-strength anti-parasitic tablets, advanced systemic toner waters, and modern pharmacological research lines globally.
Excellent crystalline density distribution and outstanding intracellular intraerythrocytic binding affinity provide a distinct operational edge when engineering modern fast-acting anti-plasmodial formulations. This active pharmaceutical solid operates by disrupting the detoxification of toxic ferriprotoporphyrin inside parasites to break down pathogen defense setups, supplying the exact chemical mechanisms required to induce rapid schizonticide clearance without altering raw pharmaceutical binder uniformity. It assists compounding engineers in maintaining strict dosage uniformity across high-speed tablet compression and bottle filling lines, mitigating trace instability risks within automated volumetric dosing machinery. For instance, specialized pharmaceutical facilities incorporate this natural cinchona powder as a core active component in targeted broad-spectrum antimalarial production. As a consequence, it maximizes the technical throughput of automated filling machinery and continuous quality assurance checks. Consequently, Zyntex coordinates clean room crystallization paths to eliminate downstream polymorph shifts from your factory schedule.
In addition to this, Zyntex coordinates climate-controlled logistics for pilot-scale trials and advanced infectious disease drug research centers. The compound maintains its refined crystalline integrity under strict storage parameters, preventing heat-induced chemical breakdown or photolytic degradation during automated mechanical blending steps. It advances contemporary medical engineering by providing a thoroughly analyzed, highly predictable anti-parasitic raw material that meets international monograph standards. Simultaneously, it remains a critical chemical standard for routine high-performance liquid chromatography (HPLC) compound calibration assays and spectrofluorometric validation testing loops. In brief, our product functions as a dependable chemical foundation, supporting both the performance of commercial clinical batches and the analytical rigor of specialized industrial laboratories.
This high-purity crystalline active drug compound delivers crucial technical value within these four primary industrial sectors:
Primary anti-parasitic hammadde source used for formulating uniform, high-bioavailability oral solid tablets. Hence, it directly supports optimal erythrocytic control lines.
Utilized as a strictly standardized bittering active component to compound professional carbonated beverages and specific alimentary syrups. Clearly, it is key for uniform dissolving patterns.
Acts as an essential reference active standard for monitoring fluorescence intensity metrics, assay calibration, and routine laboratory diagnostics. Resultantly, it guarantees excellent matrix clarity.
Used as a professional active component for validating advanced neuromuscular transmission blockades and specialized nocturnal leg cramp mitigation models. Specifically, it confirms optimal reaction pathways.
| Parameter | Standard Value |
|---|---|
| Product Name | Quinine Sulfate Dihydrate |
| Assay / Purity (HPLC) | 99.0% to 101.0% (Dry Basis) |
| Appearance | Fine, white, odorless needle-like crystalline powder |
| Specific Rotation | -235° to -245° |
| Solubility | Slightly soluble in water; sparingly soluble in boiling water; freely soluble in a mixture of chloroform and ethanol |
| CAS Number | 6119-70-7 (Dihydrate) / 804-63-7 (Anhydrous) |
⚠️ Safety & Handling (ALKALOID SENSITIZER): Quinine Sulfate is an active quinoline alkaloid pharmaceutical ingredient. Direct inhalation of crystalline needle bulk powder dust or accidental transdermal/ocular exposure poses a moderate risk of clinical cinchonism vectors, localized severe skin sensitization rashes, visual accommodation stress, and potential acute cardiac conduction delay variations. Therefore, store strictly inside original double-sealed airtight industrial containers within a cool, exceptionally dark, and secure pharmaceutical warehouse zone isolated from volatile moisture sources and protected from direct solar rays. Prevent airborne dust clouds during dispensing setups. Proper personal protective equipment (PPE)—including high-grade chemical-resistant gloves, protective safety goggles, and a certified clinical HEPA dust respirator mask—must be worn during all manufacturing handling phases. Review the Safety Data Sheet (SDS).